Healthy volunteers test two versions of experimental drug
NCT ID NCT07565597
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how two different versions of gecacitinib hydrochloride tablets are absorbed and processed by the body in healthy adults. About 64 participants aged 18 to 45 will take a single dose of each version under fasting conditions. The goal is to compare the drug levels in the blood to see if the formulations work similarly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Third Hospital of Changsha
Changsha, Hunan, China